Interpace Biosciences, Inc. (IDXG)
OTCMKTS: IDXG · Delayed Price · USD
1.540
+0.117 (8.26%)
Apr 26, 2024, 11:24 AM EDT - Market open
Interpace Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1997 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 3.5 | 4.83 | 3.31 | 2.77 | 2.32 | 6.07 | 15.2 | 0.6 | 8.31 | 23.11 | Upgrade
|
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.11 | 0.11 | Upgrade
|
Cash & Cash Equivalents | 3.5 | 4.83 | 3.31 | 2.77 | 2.32 | 6.07 | 15.2 | 0.6 | 8.42 | 23.22 | Upgrade
|
Cash Growth | -27.55% | 45.68% | 19.55% | 19.43% | -61.75% | -60.08% | 2424.75% | -92.85% | -63.75% | -49.24% | Upgrade
|
Receivables | 4.98 | 5.03 | 6.16 | 8.03 | 10.2 | 9.48 | 3.44 | 2.53 | 3.85 | 14.42 | Upgrade
|
Inventory | 1.23 | 1.22 | 1.79 | 2.05 | 1.83 | 1.23 | 0.27 | 0.01 | 5.55 | 0 | Upgrade
|
Other Current Assets | 0.61 | 1.07 | 0.91 | 1.27 | 2.03 | 0.94 | 0.91 | 1.09 | 1.34 | 7.23 | Upgrade
|
Total Current Assets | 10.32 | 12.15 | 12.17 | 14.12 | 16.37 | 17.72 | 19.81 | 4.24 | 19.17 | 44.87 | Upgrade
|
Property, Plant & Equipment | 2.65 | 2.92 | 10.38 | 11.73 | 10.71 | 0.84 | 0.65 | 0.93 | 1.46 | 3.18 | Upgrade
|
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.91 | 1.06 | Upgrade
|
Goodwill | 0 | 0 | 8.43 | 8.43 | 8.43 | 0 | 0 | 0 | 0 | 15.55 | Upgrade
|
Intangible Assets | 0 | 0.86 | 7.29 | 11.35 | 33.5 | 29.85 | 33.11 | 36.36 | 43.49 | 47.3 | Upgrade
|
Other Long-Term Assets | 0.05 | 0.05 | 0.16 | 0.04 | 0.04 | 0.03 | 0.03 | 0.25 | 2.69 | 3.95 | Upgrade
|
Total Long-Term Assets | 2.7 | 3.83 | 26.26 | 31.56 | 52.68 | 30.72 | 33.79 | 37.54 | 48.55 | 71.04 | Upgrade
|
Total Assets | 13.02 | 15.98 | 38.43 | 45.68 | 69.05 | 48.44 | 53.6 | 41.78 | 67.71 | 115.91 | Upgrade
|
Accounts Payable | 1.54 | 1.05 | 2.69 | 4.51 | 4.81 | 1.06 | 0.39 | 2.33 | 1.56 | 4.31 | Upgrade
|
Deferred Revenue | 0.26 | 0 | 0.04 | 0.05 | 0.46 | 0 | 0 | 0 | 8.39 | 6.75 | Upgrade
|
Current Debt | 5.48 | 3.08 | 1.12 | 1.2 | 1.51 | 0 | 0 | 0 | 1.16 | 19.7 | Upgrade
|
Other Current Liabilities | 10.19 | 10.16 | 11.83 | 12.46 | 10.52 | 7.43 | 7.6 | 13.92 | 12.26 | 2.82 | Upgrade
|
Total Current Liabilities | 17.47 | 14.28 | 15.68 | 18.23 | 17.3 | 8.49 | 7.99 | 16.24 | 23.37 | 33.58 | Upgrade
|
Long-Term Debt | 4.24 | 13.01 | 12.6 | 3.54 | 5.59 | 0 | 0 | 7.91 | 7.23 | 27.15 | Upgrade
|
Other Long-Term Liabilities | 6.44 | 51.76 | 52.57 | 52.99 | 33.14 | 7.01 | 5.64 | 11.1 | 24.07 | 35.05 | Upgrade
|
Total Long-Term Liabilities | 10.68 | 64.77 | 65.16 | 56.53 | 38.73 | 7.01 | 5.64 | 19.01 | 31.3 | 62.21 | Upgrade
|
Total Liabilities | 28.16 | 79.05 | 80.85 | 74.76 | 56.03 | 15.5 | 13.63 | 35.25 | 54.67 | 95.78 | Upgrade
|
Total Debt | 11.19 | 16.09 | 13.72 | 4.74 | 7.1 | 0 | 0 | 7.91 | 8.4 | 27.15 | Upgrade
|
Debt Growth | -30.45% | 17.32% | 189.12% | -33.15% | - | - | - | -5.82% | -69.08% | - | Upgrade
|
Common Stock | 0.41 | 0.41 | 0.4 | 0.4 | 0.39 | 0.29 | 0.28 | 0.02 | 0.19 | 0.17 | Upgrade
|
Retained Earnings | -248.22 | -249.02 | -227.06 | -212.12 | -168.16 | -141.49 | -131.8 | -119.58 | -111.25 | -99.9 | Upgrade
|
Comprehensive Income | -46.54 | 0 | 0 | -45.68 | -26.17 | -1.37 | -1.16 | -0 | 0.01 | 0.02 | Upgrade
|
Shareholders' Equity | -15.14 | -63.07 | -42.42 | -29.08 | 13.03 | 32.94 | 39.97 | 6.53 | 13.04 | 20.12 | Upgrade
|
Total Liabilities and Equity | 13.02 | 15.98 | 38.43 | 45.68 | 69.05 | 48.44 | 53.6 | 41.78 | 67.71 | 115.91 | Upgrade
|
Net Cash / Debt | -7.69 | -11.26 | -10.4 | -1.97 | -4.78 | 6.07 | 15.2 | -7.31 | 0.02 | -3.94 | Upgrade
|
Net Cash / Debt Growth | - | - | - | - | - | -60.08% | - | - | - | - | Upgrade
|
Net Cash Per Share | -1.76 | -2.66 | -2.52 | -0.49 | -1.27 | 2.15 | 9.64 | -40.23 | 0.12 | -26.41 | Upgrade
|
Working Capital | -7.15 | -2.13 | -3.52 | -4.11 | -0.93 | 9.23 | 11.82 | -12 | -4.21 | 11.29 | Upgrade
|
Book Value Per Share | -3.51 | -14.88 | -10.26 | -7.22 | 3.48 | 11.70 | 25.42 | 35.96 | 84.25 | 135.04 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.